[News playback] The activity of "the First Investigation of Consumer Satisfied Product Quality on Chinese Market", as hosted by the market information center of the People’s Daily, co-organized by 60 authoritative industry associations including China Association of Pharmaceutical Commerce, supported by 10 authoritative newspapers, and surveyed on such authoritative websites as people.com, soho.com and sun315.com was unveiled in March 2004. "Weisu Granules" produced by YRPG was awarded the title of "No. 1 Brand of Consumer Satisfied Product Quality on Chinese Market".
[Interpretation] Dong Jianhua, Academician of Chinese Academy of Engineering and doctor of Central Health Care Bureau, is a prestigious master on Chinese TCM. He devotes his lifetime effort to the proved prescription of Weisuyin in 1998. YRPG developed and produced the national-class Weisu Granules for treating distending pain in the stomach through six years by adopting modern craftwork and high science and technology after its obtaining of the prescription. The high, rapid and obvious effects have been acclaimed by wide sufferers and doctors upon the release of the drug. At present, as an important drug on the Chinese stomach drug market, its sales volume has been beyond 2 billion Yuan in accumulation and ranked in the "National Single Drug Champion".
[Demonstration] It is an important aspect of YRPG’s scientific development by producing more drugs and manufacturing good drugs. The frequent emergence of new products, as a strong drive of the enterprise’s rapid development, has enabled the enterprise firmly established in the increasingly competitive market. At present, YRPG has processed new drugs of 10 categories including the rheum category, the digestion system category, the cardiovascular category, the respiratory system category and the anti-biotic category, and over 10 preparation formulations as well as over 100 varieties. According to the prescription contributed by Professor Zhang Zhenyu, Ph.D. Supervisor of Shandong University of Traditional Chinese Medicine, the group successfully produced the new drug "Jingqianping Granules" for treating the female’s premenstrual syndrome, which has completed the blank of domestic drugs for treating the disease. Besides, Biling Weitong Granules has been listed as the "Necessary Medication for Emergent Treatment of Nationwide TCM Hospitals" with five products listed into the "Individual Pricing Content" by the State Planning Commission.